Guidance for surveillance of SARS-CoV-2 variants: Interim guidance, 9 August 2021

SARS-CoV-2 variant data update, England

Training on handling, storing and transporting Pfizer BioNTech COVID-19 Vaccine COMIRNATY® (Tozinameran)

Holding gatherings during the COVID-19 pandemic: WHO policy brief

Holding gatherings during the COVID-19 pandemic: WHO policy brief, 2 August 2021

Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)

Interim recommendations for use of the ChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222 Vaxzevria™, SII COVISHIELD™)

Clinical features and prognostic factors of COVID-19 in people living with HIV hospitalized with suspected or confirmed SARS-CoV-2 infection

WHO technical consultation on oxygen access scale-up for COVID-19

Safe Eid al Adha practices in the context of COVID-19

Infection prevention and control during health care when coronavirus disease (‎COVID-19)‎ is suspected or confirmed

COVID-19 Vaccines: safety surveillance manual. Module on safety surveillance of COVID-19 vaccines in pregnant and breastfeeding women

Risk assessment for SARS-CoV-2 variant: LAMBDA (VUI-21JUN-01, C.37)

Therapeutics and COVID-19: living guideline

Policy considerations for implementing a risk-based approach to international travel in the context of COVID-19

Technical considerations for implementing a risk-based approach to international travel in the context of COVID-19: Interim guidance

Implementation guidance for assessments of frontline service readiness: strengthening real-time monitoring of health services in the context of the COVID-19 pandemic

Protocol template to be used as template for observational study protocols for sentinel surveillance of adverse events of special interest (AESIs) after vaccination with COVID-19 vaccines.

Ethical Framework for WHO’s work in the ACT-Accelerator

Indicator framework for the evaluation of the public health effectiveness of digital proximity tracing solutions

Recommendations for national SARS-CoV-2 testing strategies and diagnostic capacities

Considerations for quarantine of contacts of COVID-19 cases

SARS-CoV-2 variants of concern and variants under investigation in England

Managing family risk: A facilitator’s toolbox for empowering families to manage risks during COVID-19 - Part 2

A family toolbox for managing health and happiness during COVID-19 - Part 1

Hypertension and COVID-19

Management Protocol for Long Haul COVID-19 Syndrome (LHCS)

Interim recommendations for use of the Moderna mRNA-1273 vaccine against COVID-19

Interim recommendations for the use of the Janssen Ad26.COV2.S (COVID-19) vaccine

Considerations for implementing and adjusting public health and social measures in the context of COVID-19

Update on WHO Interim recommendations on COVID-19 vaccination of pregnant and lactating women

Young people and COVID-19: Behavioural considerations for promoting safe behaviours

How to manage COVID-19 vaccines without VVM at vaccination service points?

Interim recommendations for use of the inactivated COVID-19 vaccine, CoronaVac, developed by Sinovac

Use of medical and non-medical/fabric masks for community outreach activities during the COVID-19 pandemic

Annexes to the recommendations for use of the Sinovac-CoronaVac vaccine against COVID-19: Grading of evidence, Evidence to recommendation tables

Guidance on developing a national deployment and vaccination plan for COVID-19 vaccines

Preventing and mitigating COVID-19 at work

WHO COVID-19 infection prevention and control (IPC) pillar achievements.

Programmatic innovations to address challenges in tuberculosis prevention and care during the COVID-19 pandemic

AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine

Estimating COVID-19 vaccine effectiveness against severe acute respiratory infections (‎SARI)‎ hospitalizations associated with laboratory-confirmed SARS-CoV-2: an evaluation using the test-negative design

COVID-19 Exercise Programme - Drills for Vaccine Deployment

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief

Expanding our understanding of post COVID-19 condition: report of a WHO webinar

Annexes to the interim recommendations for use of theChAdOx1-S [recombinant] vaccine against COVID-19 (AstraZeneca COVID-19 vaccine AZD1222, SII Covishield, SK Bioscience)

Disability considerations for COVID-19 vaccination: WHO and UNICEF policy brief

Asthma and COVID-19: scientific brief

Why are there extra doses of vaccine in the vaccine vial?

WHO COVID-19 essential supplies forecasting tool (‎COVID-ESFT)

Reducing public health risks associated with the sale of live wild animals of mammalian species in traditional food markets

WHO COVID-19 infection prevention and control (IPC) pillar achievements. February 2020 – January 2021

Principles for COVID-19 Vaccination in Musculoskeletal and Rheumatology for Clinicians

WHO-convened global study of origins of SARS-CoV-2: China Part

Background document on the Janssen Ad26.COV2.S (COVID-19) vaccine: Background document to the WHO Interim recommendations for use of Ad26.COV2.S (COVID-19) vaccine

How to monitor and report COVID-19 vaccine side effects

Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data

Monitoring COVID-19 vaccination: Considerations for the collection and use of vaccination data

WHO Living guideline: Drugs to prevent COVID-19

WHO Living guideline: Drugs to prevent COVID-19

COVID-19 vaccine checklist

Health worker communication for COVID-19 vaccination flow diagram

COVID-19 vaccine checklist

Operational considerations to expedite genomic sequencing component of GISRS surveillance of SARS-CoV-2

Using face masks in the community: first update - Effectiveness in reducing transmission of COVID-19

Interim recommendations for use of the AZD1222 (ChAdOx1-S (recombinant)) vaccine against COVID-19 developed by Oxford University and AstraZeneca

Global COVID-19 Clinical Platform Case Report Form (CRF) for Post COVID condition (Post COVID-19 CRF)

American Society of Hematology 2021 guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19

Definition and categorization of the timing of mother-to-child transmission of SARS-CoV-2

Data for action: achieving high uptake of COVID-19 vaccines: Interim Guidance

Background document on the mRNA-1273 vaccine (Moderna) against COVID-19

Contact tracing in the context of COVID-19

Protocolos de atención odontológica ante la nueva realidad por COVID-19

Laboratory biosafety guidance related to coronavirus disease (COVID-19): Interim guidance, 28 January 2021

Recomendaciones FACME para la vacunación frente a COVID-19

Las nuevas cepas del SARS-CoV-2, ¿qué se sabe?

COVID-19 Clinical management: living guidance

Actualización - Estrategia de vacunación frente a COVID-19 en España

Online global consultation on contact tracing for COVID-19, 9-11 June 2020

Strategies for Optimizing the Supply of Isolation Gowns

mRNA-1273 vaccine (Moderna) against COVID-19 Background document (draft)

Sequencing of SARS-CoV-2 - Version 1

WHO public health research agenda for managing infodemics

Investigational COVID-19 Convalescent Plasma

Protecting Participants in Bioequivalence Studies for Abbreviated New Drug Applications During the COVID-19 Public Health Emergency

Aide-memoire: Infection prevention and control (IPC) principles and procedures for COVID-19 vaccination activities

Coronavirus Disease 2019 (COVID-19) Treatment Guidelines

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

Analysing and using routine data to monitor the effects of COVID-19 on essential health services: practical guide for national and subnational decision-makers

Coagulation Systems for Measurement of Viscoelastic Properties: Enforcement Policy During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency

COVID-19: Potency Assay Considerations for Monoclonal Antibodies and Other Therapeutic Proteins Targeting SARS-CoV-2 Infectivity

Product Information as approved by the CHMP on 8 January 2021, pending endorsement by the European Commission

Interim recommendations for use of the Pfizer–BioNTech COVID-19 vaccine, BNT162b2, under Emergency Use Listing

Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health

SARS-CoV-2 genomic sequencing for public health goals: Interim guidance

Infection prevention and control guidance for long-term care facilities in the context of COVID-19 update

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19 - Version 3.6.0

COVID-19 Rapid Response Team Guidance

How to Make 0.1% Chlorine Solution to Disinfect Surfaces in Healthcare Settings

¿Cómo atender a pacientes con COVID-19?

Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic

CHMP summary of positive opinion for COVID-19 Vaccine Moderna

COVID-19 Vaccine Moderna - Product information

Summary of the Risk Management Plan for COVID-19 Vaccine Moderna

Guidance on Providing Pediatric Well-Care During COVID-19

COVID-19 Guidance for Safe Schools

Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic

Risk of False Results with the Curative SARS-Cov-2 Test for COVID-19: FDA Safety Communication

Capacitación para personal de salud sobre vacunación contra la COVID-19: Módulos

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

COVID-19 Testing Guidance

Cloth Face Coverings

Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic

Information for Pediatric Healthcare Providers

COVID-19 Global Risk Communication and Community Engagement Strategy

Evidence to recommendations: Methods used for assessing health equity and human rights considerations in COVID-19 and aviation

COVID-19 in children and the role of school settings in transmission - Version 1

Rational use of personal protective equipment for coronavirus disease (COVID-19) and considerations during severe shortages

Comirnaty : EPAR - All authorised presentations

Comirnaty : EPAR - Public assessment report

Commission adopts Recommendation on EU coordinated approach to travel and transport in response to new variant of coronavirus in the UK

COVID-19 vaccination and prioritisation strategies in the EU/EEA

Comirnaty: EPAR - Product Information

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

CHMP summary of positive apinion for Comirnaty

COVID-19 rapid guideline: managing the long-term effects of COVID-19

Emergency Use Designation of COVID-19 candidate vaccines: Ethical considerations for current and future COVID-19placebo-controlled vaccine trials and trial unblinding

Proposal for a council recommendation on a common framework for the use, validation and mutual recognition of COVID-19 rapid antigen tests in the EU

Coronavirus (covid-19): medidas de prevención y control de la infección

Since advice in a crisis

COVID-19 rapid guideline: vitamin D

Therapeutics and COVID-19: living guideline - 3rd Version

Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities

Emergency Global Supply Chain System (COVID-19) catalogue

Vaccines and Related Biological Products Advisory Committee Meeting

Considerations for implementing a risk-based approach to international travel in the context of COVID-19

Risk assessment tool to inform mitigation measures for international travel in the context of COVID-19

COVID-19 diagnostic testing in the context of international travel

Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities

Evidence to recommendations: COVID-19 mitigation in the aviation sector: Interim guidance - Corrigenda

Testing Healthcare Personnel

Potential Exposure at Work

Mitigating Staff Shortages

Infection Control Guidance

Coronavirus (COVID-19): evidencia relevante para cuidados críticos

COVID-19 vaccine introduction and deployment costing tool

Coronavirus disease 2019 (COVID-19) and supply ofsubstances of human origin in the EU/EEA - 2nd update

Information for Healthcare Professionals on Pfizer/BioNTech COVID-19 vaccine

Checklist to support schools re-opening and preparation for COVID-19 resurgences or similar public health crises

Winter Holidays

Supporting Healthy Nutrition and Physical Activity During the COVID-19 Pandemic

Obesity Management and Treatment During COVID-19

Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)

Interim Guidance for Antigen Testing for SARS-CoV-2

COVID-19 Interim Guidance: Return to Sports

Summary of Guidance for Public Health Strategies to Address High Levels of Community Transmission of SARS-CoV-2 and Related Deaths

Guidance for Dental Settings

Corrigenda – Maintaining surveillance of influenza and monitoring SARS-CoV-2

Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings

Care for Breastfeeding Women

Guidelines for COVID-19 testing and quarantine of air travellers - Addendum to the Aviation Health Safety Protocol

Feasibility, Potential Value and Limitations of Establishing a Closely Monitored Challenge Model of Experimental COVID-19 Infection and Illness in Healthy Young Adult Volunteers

Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel

Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection

Mask use in the context of COVID-19

CDC Guidance for Expanded Screening Testing to Reduce Silent Spread of SARS-CoV-2

Guidance for Health Departments about COVID-19 Testing in the Community

Know When to Delay your Travel to Avoid Spreading COVID-19

Staying safe from COVID-19 during winter

Recommandations pour les repas de Noël

Public Health Guidance for Potential COVID-19 Exposure Associated with International or Domestic Travel

Local restriction tiers: what you need to know

Evidence to recommendations: COVID-19 mitigation in the aviation sector

Rapid hospital readiness checklist: Interim Guidance

Draft landscape of COVID-19 candidate vaccines – 26 November 2020

Know When to Delay your Travel to Avoid Spreading COVID-19

Strategies for Optimizing the Supply of Facemasks

Investigating a COVID-19 Case

Contact Tracing for COVID-19

Strategies for Optimizing the Supply of N95 Respirators

Prioritizing Case Investigations and Contact Tracing for COVID-19 in High Burden Jurisdictions

Polling Locations and Voters

Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings

Prioritizing COVID-19 Contact Tracing Mathematical Modeling Methods and Findings

Collection and Submission of Postmortem Specimens from Deceased Persons with Known or Suspected COVID-19

COVID-19 rapid guideline: reducing the risk of venous thromboembolism in over 16s with COVID-19

Therapeutics and COVID-19: living guideline - 2nd Version

Continuity of essential health services: Facility assessment tool

Diagnostics, therapeutics, vaccine readiness, and other health products for COVID-19

Priority medical devices list for the COVID-19 response and associated technical specifications

Preparing for COVID-19 in Nursing Homes

Maintaining surveillance of influenza and monitoring SARS-CoV-2 – adapting Global Influenza surveillance and Response System (GISRS) and sentinel systems during the COVID-19 pandemic

Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: non-US Healthcare Settings

Cleaning, Disinfection, and Hand Hygiene in Schools – a Toolkit for School Administrators

Options for the use of rapid antigen tests for COVID-19 in the EU/EEA and the UK

Contact tracing: public health management of persons, including healthcare workers, who have had contact with COVID-19 cases in the European Union – third update

The COVID-19 Treatment Guidelines Panel’s Statement on the Emergency Use Authorization of Bamlanivimab for the Treatment of COVID-19

Interim Operational Considerations for Public Health Management of Healthcare Workers Exposed to or with Suspected or Confirmed COVID-19: non-U.S. Healthcare Settings

Considerations for Restaurant and Bar Operators

Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance